U.S. Markets close in 2 hrs 22 mins
  • S&P 500

    -22.53 (-0.60%)
  • Dow 30

    -223.89 (-0.74%)
  • Nasdaq

    -28.38 (-0.25%)
  • Russell 2000

    -2.33 (-0.13%)
  • Crude Oil

    +0.37 (+0.42%)
  • Gold

    -0.10 (-0.01%)
  • Silver

    +0.11 (+0.52%)

    -0.0174 (-1.7465%)
  • 10-Yr Bond

    +0.0340 (+0.90%)
  • Vix

    +1.08 (+3.78%)

    -0.0308 (-2.6877%)

    +0.7520 (+0.5215%)

    -88.83 (-0.44%)
  • CMC Crypto 200

    -5.55 (-1.20%)
  • FTSE 100

    -55.35 (-0.78%)
  • Nikkei 225

    +190.77 (+0.70%)

Avalon GloboCare Corp. (NASDAQ:AVCO) Insiders Increased Their Holdings

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Avalon GloboCare Corp. (NASDAQ:AVCO).

What Is Insider Selling?

It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, most countries require that the company discloses such transactions to the market.

We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Colombia University study found that ‘insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers’.

See our latest analysis for Avalon GloboCare

The Last 12 Months Of Insider Transactions At Avalon GloboCare

Over the last year, we can see that the biggest insider purchase was by Steven Sukel for US$345k worth of shares, at about US$4.00 per share. That means that an insider was happy to buy shares at above the current price. Their view may have changed since then, but at least it shows they felt optimistic at the time. That purchase may suggest an expectation of positive returns over the long term. Steven Sukel was the only individual insider to buy shares in the last twelve months.

Steven Sukel bought 217.72k shares over the last 12 months at an average price of US$1.60. You can see a visual depiction of insider transactions over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqCM:AVCO Insider Trading December 26th 18
NasdaqCM:AVCO Insider Trading December 26th 18

I will like Avalon GloboCare better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It’s great to see that Avalon GloboCare insiders own 72% of the company, worth about US$146m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About Avalon GloboCare Insiders?

There haven’t been any insider transactions in the last three months — that doesn’t mean much. However, our analysis of transactions over the last year is heartening. With high insider ownership and encouraging transactions, it seems like Avalon GloboCare insiders think the business has merit. I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.